Robert F McGivern

Title: The Innovations of Robert F McGivern

Introduction

Robert F McGivern is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biochemistry, particularly in the area of peptide research. His work has implications for understanding and treating various diseases related to corticotropin release.

Latest Patents

Robert F McGivern holds a patent for a peptide with corticotropin release inhibiting factor (CRIF) activity. This invention includes a substantially pure preparation of a peptide comprising at least three contiguous amino acids within the amino acid sequence positioned between the fourth and fifth thyrotropin releasing hormone (TRH) sequence on a prepro-TRH protein. The CRIF peptide also includes the fourth uncleaved TRH portion of prepro-TRH positioned at the amino terminus of CRIF. The patent encompasses compositions, methods of diagnosis, and methods for treating CRIF-related diseases. He has 1 patent to his name.

Career Highlights

Robert F McGivern is affiliated with the University of Pennsylvania, where he continues to engage in innovative research. His work has contributed to advancements in understanding the mechanisms of corticotropin release and its implications for health.

Collaborations

He has collaborated with notable colleagues, including Eva E Redei and Fraser Aird, to further explore the applications of his research in the medical field.

Conclusion

Robert F McGivern's contributions to peptide research and his innovative patent highlight his role as a significant figure in the scientific community. His work continues to pave the way for advancements in the treatment of CRIF-related diseases.